These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 11741469)
1. Characterization of the 1H-cyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization properties. Campiani G; Morelli E; Nacci V; Fattorusso C; Ramunno A; Novellino E; Greenwood J; Liljefors T; Griffiths R; Sinclair C; Reavy H; Kristensen AS; Pickering DS; Schousboe A; Cagnotto A; Fumagalli E; Mennini T J Med Chem; 2001 Dec; 44(26):4501-4. PubMed ID: 11741469 [TBL] [Abstract][Full Text] [Related]
2. Inherent desensitisation-preventing properties of a novel, subtype-selective AMPA receptor agonist, (S)-CPW 399, as a possible explanation for its excitotoxic action in cultured cerebellar granule cells. Sinclair C; Reavy H; Grieve A; Schousboe A; Morelli E; Novellino E; Campiani G; Griffiths R Neurochem Int; 2003 May; 42(6):499-510. PubMed ID: 12547649 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes. Jane DE; Hoo K; Kamboj R; Deverill M; Bleakman D; Mandelzys A J Med Chem; 1997 Oct; 40(22):3645-50. PubMed ID: 9357531 [TBL] [Abstract][Full Text] [Related]
4. 3-hydroxypyridazine 1-oxides as carboxylate bioisosteres: a new series of subtype-selective AMPA receptor agonists. Greenwood JR; Mewett KN; Allan RD; Martín BO; Pickering DS Neuropharmacology; 2006 Jul; 51(1):52-9. PubMed ID: 16631211 [TBL] [Abstract][Full Text] [Related]
5. 1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of potent and Selective iGluR5 modulators. Butini S; Pickering DS; Morelli E; Coccone SS; Trotta F; De Angelis M; Guarino E; Fiorini I; Campiani G; Novellino E; Schousboe A; Christensen JK; Gemma S J Med Chem; 2008 Oct; 51(20):6614-8. PubMed ID: 18811139 [TBL] [Abstract][Full Text] [Related]
6. (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology. Brehm L; Greenwood JR; Hansen KB; Nielsen B; Egebjerg J; Stensbøl TB; Bräuner-Osborne H; Sløk FA; Kronborg TT; Krogsgaard-Larsen P J Med Chem; 2003 Apr; 46(8):1350-8. PubMed ID: 12672235 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO). Bjerrum EJ; Kristensen AS; Pickering DS; Greenwood JR; Nielsen B; Liljefors T; Schousboe A; Bräuner-Osborne H; Madsen U J Med Chem; 2003 May; 46(11):2246-9. PubMed ID: 12747796 [TBL] [Abstract][Full Text] [Related]
8. Stereochemistry and molecular pharmacology of (S)-thio-ATPA, a new potent and selective GluR5 agonist. Stensbøl TB; Jensen HS; Nielsen B; Johansen TN; Egebjerg J; Frydenvang K; Krogsgaard-Larsen P Eur J Pharmacol; 2001 Jan; 411(3):245-53. PubMed ID: 11164381 [TBL] [Abstract][Full Text] [Related]
10. Resolution, configurational assignment, and enantiopharmacology of 2-amino-3-[3-hydroxy-5-(2-methyl-2H- tetrazol-5-yl)isoxazol-4-yl]propionic acid, a potent GluR3- and GluR4-preferring AMPA receptor agonist. Vogensen SB; Jensen HS; Stensbøl TB; Frydenvang K; Bang-Andersen B; Johansen TN; Egebjerg J; Krogsgaard-Larsen P Chirality; 2000 Nov; 12(10):705-13. PubMed ID: 11054828 [TBL] [Abstract][Full Text] [Related]
11. Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid. Johansen TN; Ebert B; Bräuner-Osborne H; Didriksen M; Christensen IT; Søby KK; Madsen U; Krogsgaard-Larsen P; Brehm L J Med Chem; 1998 Mar; 41(6):930-9. PubMed ID: 9526567 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors. Dolman NP; Troop HM; More JC; Alt A; Knauss JL; Nistico R; Jack S; Morley RM; Bortolotto ZA; Roberts PJ; Bleakman D; Collingridge GL; Jane DE J Med Chem; 2005 Dec; 48(24):7867-81. PubMed ID: 16302825 [TBL] [Abstract][Full Text] [Related]
13. Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA. Stensbøl TB; Borre L; Johansen TN; Egebjerg J; Madsen U; Ebert B; Krogsgaard-Larsen P Eur J Pharmacol; 1999 Sep; 380(2-3):153-62. PubMed ID: 10513575 [TBL] [Abstract][Full Text] [Related]
14. AMPA receptor agonists: resolution, configurational assignment, and pharmacology of (+)-(S)- and (-)-(R)-2-amino-3-[3-hydroxy-5-(2-pyridyl)-isoxazol-4-yl]-propionic acid (2-Py-AMPA). Johansen TN; Ebert B; Falch E; Krogsgaard-Larsen P Chirality; 1997; 9(3):274-80. PubMed ID: 9176992 [TBL] [Abstract][Full Text] [Related]
15. Structural determinants of AMPA agonist activity in analogues of 2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid: synthesis and pharmacology. Bang-Andersen B; Ahmadian H; Lenz SM; Stensbøl TB; Madsen U; Bøgesø KP; Krogsgaard-Larsen P J Med Chem; 2000 Dec; 43(25):4910-8. PubMed ID: 11124000 [TBL] [Abstract][Full Text] [Related]
16. Tweaking Subtype Selectivity and Agonist Efficacy at (S)-2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propionic acid (AMPA) Receptors in a Small Series of BnTetAMPA Analogues. Wang SY; Larsen Y; Navarrete CV; Jensen AA; Nielsen B; Al-Musaed A; Frydenvang K; Kastrup JS; Pickering DS; Clausen RP J Med Chem; 2016 Mar; 59(5):2244-54. PubMed ID: 26862980 [TBL] [Abstract][Full Text] [Related]